Literature DB >> 16943795

Low testosterone levels are associated with coronary artery disease in male patients with angina.

G M C Rosano1, I Sheiban, R Massaro, P Pagnotta, G Marazzi, C Vitale, G Mercuro, M Volterrani, A Aversa, M Fini.   

Abstract

Historically, high androgen levels have been linked with an increased risk for coronary artery disease (CAD). However, more recent data suggest that low androgen levels are associated with adverse cardiovascular risk factors, including an atherogenic lipid profile, obesity and insulin resistance. The aim of the present study was to evaluate the relationship between plasma sex hormone levels and presence and degree of CAD in patients undergoing coronary angiography and in matched controls. We evaluated 129 consecutive male patients (mean age 58+/-4 years, range 43-72 years) referred for diagnostic coronary angiography because of symptoms suggestive of CAD, but without acute coronary syndromes or prior diagnosis of hypogonadism. Patients were matched with healthy volunteers. Out of 129 patients, 119 had proven CAD; in particular, 32 of them had one, 63 had two and 24 had three vessel disease, respectively. Patients had significantly lower levels of testosterone than controls (9.8+/-6.5 and 13.5+/-5.4 nmol/l, P<0.01) and higher levels of gonadotrophin (12.0+/-1.5 vs 6.6+/-1.9 IU/l and 7.9+/-2.1 vs 4.4+/-1.4, P<0.01 for follicle-stimulating hormone and luteinizing hormone, respectively). Also, both bioavailable testosterone and plasma oestradiol levels were lower in patients as compared to controls (0.84+/-0.45 vs 1.19+/-0.74 nmol/l, P<0.01 and 10.7+/-1.4 vs 13.3+/-3.5 pg/ml, P<0.05). Hormone levels were compared in cases with one, two or three vessel disease showing significant differences associated with increasing severity of coronary disease. An inverse relationship between the degree of CAD and plasma testosterone levels was found (r=-0.52, P<0.01). In conclusion, patients with CAD have lower testosterone and oestradiol levels than healthy controls. These changes are inversely correlated to the degree of CAD, suggesting that low plasma testosterone may be involved with the increased risk of CAD in men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943795     DOI: 10.1038/sj.ijir.3901504

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  44 in total

Review 1.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

Review 2.  Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.

Authors:  Arthur P Arnold; Lisa A Cassis; Mansoureh Eghbali; Karen Reue; Kathryn Sandberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

3.  Left ventricular dysfunction and subclinical atherosclerosis in children with classic congenital adrenal hyperplasia: a single-center study from upper Egypt.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly; Tahra Sherief
Journal:  Eur J Pediatr       Date:  2015-09-21       Impact factor: 3.183

Review 4.  Testosterone in men with hypogonadism and high cardiovascular risk, Pros.

Authors:  Giuseppe M C Rosano; Cristiana Vitale; Massimo Fini
Journal:  Endocrine       Date:  2015-03-07       Impact factor: 3.633

Review 5.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 6.  Experimental and early investigational drugs for angina pectoris.

Authors:  Islam Y Elgendy; David E Winchester; Carl J Pepine
Journal:  Expert Opin Investig Drugs       Date:  2016-11-14       Impact factor: 6.206

Review 7.  Update on Testosterone Replacement Therapy in Hypogonadal Men.

Authors:  Kevin Matthew Yen Bing Leung; Khalid Alrabeeah; Serge Carrier
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

8.  Peroxynitrite mediates testosterone-induced vasodilation of microvascular resistance vessels.

Authors:  Yashoda Puttabyatappa; John N Stallone; Adviye Ergul; Azza B El-Remessy; Sanjiv Kumar; Stephen Black; Maribeth Johnson; Mary P Owen; Richard E White
Journal:  J Pharmacol Exp Ther       Date:  2013-01-14       Impact factor: 4.030

9.  Angina treatments and prevention of cardiac events: an appraisal of the evidence.

Authors:  David E Winchester; Carl J Pepine
Journal:  Eur Heart J Suppl       Date:  2015-12-16       Impact factor: 1.803

Review 10.  Welcoming low testosterone as a cardiovascular risk factor.

Authors:  M Maggio; S Basaria
Journal:  Int J Impot Res       Date:  2009-06-18       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.